Loading...

PE anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M170_PE_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_CD11b_Antibody_IHC_031413
    Fixed whole mount mouse spleen was stained with Alexa Fluor® 488 F4/80 (red) (clone BM8), Brilliant Violet 421™ CD3ε (green) (clone 145-2C11), and PE CD11b (blue) (clone M1/70). Isotype controls at the same concentrations were used for the negative control. Cells were mounted in Prolong Gold and imaged with a Leica SP8 confocal. Image courtesy of Grzegorz Chodaczek and Zbigniew Mikulski at LIAI.
Compare all formats See PE spectral data See more IHC data...
Cat # Size Price Quantity Check Availability Save
101207 50 µg 56 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101208 200 µg 173 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/mL
Storage & Handling
The CD11b antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
IHC - Verified
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  2. Li A, et al. 2020. Oncol Lett. 1.899305556. PubMed
  3. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  4. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  5. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  6. Nigam S, et al. 2020. Mol Imaging Biol. 22:685. PubMed
  7. Hu K, et al. 2022. J Extracell Vesicles. 11:e12199. PubMed
  8. Chida J, et al. 2020. PLoS Pathog. 16:e1008823. PubMed
  9. Guo Y, et al. 2021. Exp Ther Med. 353:21. PubMed
  10. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  11. Ho YH, et al. 2019. Cell Stem Cell. 25:407. PubMed
  12. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  13. Yates AG, et al. 2021. J Neuroinflammation. 18:15. PubMed
  14. Witherel CE, et al. 2021. Biomaterials. 269:120667. PubMed
  15. DeBuque RJ, et al. 2022. Dev Dyn. 251:988. PubMed
  16. He D, et al. 2022. Immunity. 55:159. PubMed
  17. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  18. Shang SQ, et al. 2022. Neoplasma. 69:755. PubMed
  19. Tan YY, et al. 2022. Bio Protoc. 12:e4307. PubMed
  20. Wemlinger SM, et al. 2022. J Immunol. 208:1566. PubMed
  21. Li Y, et al. 2022. J Exp Clin Cancer Res. 41:128. PubMed
  22. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  23. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  24. Qin L, et al. 2022. Sci Adv. 8:eabn3774. PubMed
  25. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  26. Albayrak E, et al. 2022. J Cell Biochem. 123:2009. PubMed
  27. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  28. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  29. McNamara NB, et al. 2023. Nature. 613:120. PubMed
  30. Sundarasivarao PYK, et al. 2022. Front Immunol. 13:1011944. PubMed
  31. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  32. Ullah I, et al. 2023. Cell Rep Med. 4:100893. PubMed
  33. Pavliuchenko N, et al. 2023. Front Immunol. 13:1035226. PubMed
  34. Marritt KL, et al. 2023. Front Immunol. 13:1087991. PubMed
  35. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  36. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  37. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  38. Citro A, et al. 2023. Nat Commun. 14:878. PubMed
  39. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  40. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  41. Marsh SE, et al. 2022. Nat Neurosci. 25:306. PubMed
  42. Ajay AK, et al. 2022. Cell Rep. 38:110473. PubMed
  43. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  44. Ramdas B, et al. 2022. Mol Ther. 30:2505. PubMed
  45. Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed
  46. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  47. Glorieux C, et al. 2022. J Adv Res. 40:109. PubMed
  48. Krasniewski LK, et al. 2022. Elife. 11:. PubMed
  49. Wu Q, et al. 2023. Front Immunol. 13:1081719. PubMed
  50. Suzuki Y, et al. 2023. Front Immunol. 14:1089905. PubMed
  51. Zhang L, et al. 2023. Commun Biol. 6:211. PubMed
  52. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  53. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  54. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  55. Mascarau R, et al. 2023. J Cell Biol. 222:. PubMed
  56. Okano F, et al. 2023. Cancer Res Commun. 3:640. PubMed
  57. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  58. Petenkova A, et al. 2023. Nat Commun. 14:2761. PubMed
  59. Xu J, et al. 2023. Discov Oncol. 14:68. PubMed
  60. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  61. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  62. Zhao C, et al. 2023. NPJ Regen Med. 8:29. PubMed
  63. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  64. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  65. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  66. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  67. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  68. Yan F, et al. 2022. Cancer Discov. 12:792. PubMed
  69. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  70. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  71. Deng Y, et al. 2021. Acta Pharmacol Sin. 42:149. PubMed
  72. Pan J, et al. 2021. Mol Ther Nucleic Acids. 26:970. PubMed
  73. Bhatt K, et al. 2018. mSphere. 3:e00352. PubMed
  74. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  75. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  76. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  77. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  78. Lei G, et al. 2016. Antimicrob Agents Chemother. 60: 1289 - 1297. PubMed
  79. Xiao X, et al. 2020. J Hematol Oncol. 0.597222222. PubMed
  80. Elkabets M, et al. 2009. J Immunol. 182:4874. PubMed
  81. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  82. Conforti A, et al. 2021. PLoS One. 16:e0259894. PubMed
  83. Götz P, et al. 2022. Int J Mol Sci. 23:. PubMed
  84. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  85. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  86. Dumas SJ, et al. 2021. STAR Protocols. 2(3):100523. PubMed
  87. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  88. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  89. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  90. Li X, et al. 2015. Proc Natl Acad Sci U S A. 112:6080. PubMed
  91. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  92. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  93. Shears RK, et al. 2020. J Allergy Clin Immunol. 145:1272. PubMed
  94. Chen X, et al. 2021. Cell Death Differ. 28:1237. PubMed
  95. Stolp B, et al. 2022. Cell Rep. 38:110387. PubMed
  96. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  97. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  98. Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed
  99. Jard T, et al. 2020. Cell Stem Cell. 27(4):646-662.e7. PubMed
  100. Forte D, et al. 2020. Cell Metab. 32:829. PubMed
  101. Llewellyn GN, et al. 2018. J Neurovirol. 24:192. PubMed
  102. Sun Y et al. 2018. Cancer cell. 34(4):643-658 . PubMed
  103. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  104. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  105. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  106. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  107. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  108. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  109. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  110. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  111. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  112. Kalucka J, et al. 2020. Cell. 764:180. PubMed
  113. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  114. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  115. Turkowski K, et al. 2017. Glia. 10.1002/glia.23234. PubMed
  116. Wiese A, et al. 2017. PLoS One. 10.1371/journal.pone.0184956. PubMed
  117. Hengyou Weng et al. 2018. Cell stem cell. 22(2):191-205 . PubMed
  118. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  119. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  120. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  121. Price J, et al. 2015. Diabetes. 64: 3521 - 3531. PubMed
  122. Pan J, et al. 2020. J Neuroinflammation. 17:97. PubMed
  123. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  124. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  125. Rogawski DS, et al. 2021. Nat Commun. 12:2792. PubMed
  126. Trenevska I, et al. 2021. PLoS One. 16:e0249967. PubMed
  127. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  128. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  129. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  130. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  131. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  132. Paraiso HC, et al. 2018. J Neuroinflammation. 0.694444444. PubMed
  133. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  134. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  135. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  136. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  137. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
  138. Huang L, et al. 2016. J Biol Chem. 291: 6232 - 6244. PubMed
  139. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  140. Nakaya M, et al. 2017. J Clin Invest. 127:383. PubMed
  141. Mayo L, et al. 2008. J Immunol. 181:92. PubMed
  142. Zheng Y, et al. 2022. Front Pharmacol. 12:816032. PubMed
  143. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  144. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  145. Zhang X, et al. 2022. Cells. 11:. PubMed
  146. Donley DW, et al. 2021. PLOS ONE. 16(5):e0250606. PubMed
  147. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  148. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  149. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  150. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  151. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
  152. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  153. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  154. Zhang S, et al. 2019. Mol Med Rep. 19:5377. PubMed
  155. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  156. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  157. Xiao Z, et al. 2015. Cancer Lett. 360:302. PubMed
  158. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  159. Keshavarz M, et al. 2020. Virol J. 17:64. PubMed
  160. He L, et al. 2019. iScience. 0.790972222. PubMed
  161. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  162. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  163. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  164. Jin R, et al. 2020. Mol Cancer Ther. . PubMed
  165. Nguyen TKT, et al. 2020. Am J Pathol. 286:190. PubMed
  166. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  167. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  168. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  169. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  170. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  171. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  172. Hou M, et al. 2020. Stem Cell Res Ther. 11:55. PubMed
  173. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  174. Malekghasemi S, et al. 2020. Cell Biol Int. 44:2031. PubMed
  175. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  176. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  177. Hildebrand KM, et al. 2021. PLoS One. 16:e0253864. PubMed
  178. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  179. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  180. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  181. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  182. Li L, et al. 2015. J Am Soc Nephrol. 26: 2183-2197. PubMed
  183. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  184. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  185. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  186. Lin S, et al. 2022. Nat Commun. 13:3301. PubMed
  187. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  188. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  189. Nguyen GT, et al. 2021. iScience. 24(8):102871. PubMed
  190. Garg M, et al. 2021. Cell Reports. 34(6):108736. PubMed
  191. Cao DY, et al. 2020. J Biol Chem. 295:1369. PubMed
  192. Moorlag SJCFM, et al. 2020. Cell Rep. 33:108387. PubMed
  193. Luong-Gardiol N, et al. 2019. Cancer Cell. 35:649. PubMed
  194. Murray C, et al. 2018. Lab Chip. 18:2396. PubMed
  195. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  196. Baik JE, et al. 2022. Clin Transl Med. 12:e758. PubMed
  197. Koshida R, et al. 2015. Biochem Biophys Res Commun. 463: 109-115. PubMed
  198. Textor A, et al. 2014. Cancer Res. 74:6769. PubMed
  199. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  200. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  201. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  202. Yang Y, et al. 2022. Elife. 11:. PubMed
  203. Bolkhovitina EL, et al. 2022. Int J Mol Sci. 23: . PubMed
  204. Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed
  205. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  206. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  207. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  208. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  209. He J, et al. 2019. J Clin Invest. 130. PubMed
  210. Huang Y, et al. 2019. Cancer Cell. 35:677. PubMed
  211. Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed
  212. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  213. Kan X, et al. 2015. Cardiovasc Res. 10.1093/cvr/cvv255. PubMed
  214. Wang L, et al. 2012. PLoS One. 7:e40056. PubMed
  215. Staschke K, et al. 2009. J Immunol. 183:568. PubMed
  216. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
  217. Perez-Garcia CG, et al. 2022. Mol Ther Nucleic Acids. 28:87. PubMed
  218. Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
  219. Zhai K, et al. 2021. Nat Cancer. 2:1136. PubMed
  220. Chiang HY, et al. 2022. Nat Commun. 13:874. PubMed
  221. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  222. Bermejo-Jambrina M, et al. 2021. EMBO J. 40:e106765. PubMed
  223. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  224. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  225. Sokol L, et al. 2021. STAR Protocols. 2(2):100489. PubMed
  226. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  227. Troutman TD, et al. 2021. STAR Protocols. 2(1):100363. PubMed
  228. Minuesa G, et al. 2019. Nat Commun. 10:2691. PubMed
  229. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  230. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  231. Wang Q, et al. 2018. Int J Biol Sci. 14:147. PubMed
  232. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  233. Tan S, et al. 2006. J Immunol. 176:2872. PubMed
  234. Roy AG, et al. 2021. Int J Mol Sci. 22:. PubMed
  235. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  236. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  237. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  238. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  239. Babagana M, et al. 2021. Aging (Albany NY). 13:19207. PubMed
  240. Li Q, et al. 2022. Front Cardiovasc Med. 9:872102. PubMed
  241. Dungan CM, et al. 2022. Aging Cell. 21:e13528. PubMed
  242. Favuzzi E, et al. 2021. Cell. 184(15):4048-4063.e32. PubMed
  243. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  244. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  245. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  246. Gomez–Ospina N, et al. 2019. Nat Commun. 3.225694444. PubMed
  247. Langhauser F, et al. 2014. Stroke. 45:1799. PubMed
  248. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  249. Demers M, et al. 2012. Proc Natl Acad Sci U S A. 109:13076. PubMed
  250. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  251. Szeifert V, et al. 2021. Front Immunol. 12:671995. PubMed
  252. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  253. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  254. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  255. Cao W, et al. 2021. Int J Mol Sci. 22:. PubMed
  256. Calle P, et al. 2021. Cells. 10:. PubMed
  257. Li T, et al. 2021. J Neuroinflammation. 81:18. PubMed
  258. Guo M, et al. 2020. Brain. 1476:143. PubMed
  259. Houben T, et al. 2020. J Pathol. 251:429. PubMed
  260. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  261. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  262. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  263. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  264. Xiao G, et al. 2018. Cell. 173:470. PubMed
  265. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  266. Wu ZJ, et al. 2018. Int J Oncol. 52:1209. PubMed
  267. Li L, et al. 2014. J Immunol. 192:1034. PubMed
  268. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  269. Yuan Y, et al. 2020. Front Physiol. 0.967361111. PubMed
  270. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  271. Toyohara T, et al. 2020. Cell Stem Cell. 27:147. PubMed
  272. Dong Y, et al. 2021. Commun Biol. 4:560. PubMed
  273. Scheiblich H, et al. 2021. Cell. 184:5089. PubMed
  274. Bennett FC, et al. 2018. Neuron. 98:1170. PubMed
  275. Zhang T, et al. 2018. PLoS One. 13:e0196571. PubMed
  276. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  277. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  278. Ding H, et al. 2016. Nat Commun. 7:11533. PubMed
  279. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  280. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  281. Wang X, et al. 2021. Cell. 184:5357. PubMed
  282. Li Y, et al. 2020. Theranostics. 10:2897. PubMed
  283. Xia D, et al. 2022. Mol Neurodegener. 17:41. PubMed
  284. Koide S, et al. 2022. iScience. 25:103603. PubMed
  285. Lin T, et al. 2021. PLoS Pathog. 17:e1009557. PubMed
  286. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  287. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  288. Lin KH, et al. 2020. Nat Genet. 52:408. PubMed
  289. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  290. Gerdes P, et al. 2022. Nat Commun. 13:7470. PubMed
  291. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  292. Jablonski K, et al. 2015. PLoS One. 10: 0145342. PubMed
  293. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  294. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  295. Resende M, et al. 2013. J Immunol. 191:262. PubMed
  296. Schaftenaar FH, et al. 2019. Sci Rep. 9:17391. PubMed
  297. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  298. Nguyen GT, et al. 2020. eLife. 9:e56656.. PubMed
  299. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  300. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  301. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  302. Avalle L, et al. 2020. Mol Ther Methods Clin Dev. 0.793055556. PubMed
  303. Zhou Q, et al. 2020. Nat Immunol. 1.393055556. PubMed
  304. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  305. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  306. Zhang A, et al. 2021. Theranostics. 11:3839. PubMed
  307. Wang Z et al. 2019. Cell reports. 26(5):1273-1285 . PubMed
  308. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  309. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  310. Schmidt C, et al. 2005. J Immunol. 175:2286. PubMed
  311. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  312. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  313. Zhang X, et al. 2022. J Exp Clin Cancer Res. 41:246. PubMed
  314. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  315. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  316. Bahmani B, et al. 2021. Nat Commun. 12:1999. PubMed
  317. Fielding C, et al. 2022. Nat Commun. 13:543. PubMed
  318. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  319. Danne C et al. 2017. Cell host & microbe. 22(6):733-745 . PubMed
  320. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  321. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  322. Baruch K, et al. 2015. EMBO J. 34: 1816 - 1828. PubMed
  323. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  324. Zhang M, et al. 2019. Autophagy. 1.423611111. PubMed
  325. Gawish R, et al. 2022. Elife. 11:. PubMed
  326. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  327. Evavold CL, et al. 2021. Cell. 184(17):4495-4511.e19. PubMed
  328. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  329. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  330. Henkle TR, et al. 2021. Cancer Res. 81:4560. PubMed
  331. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  332. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  333. Wang T, et al. 2022. Int J Nanomedicine. 17:2191. PubMed
  334. Hirako N, et al. 2014. PLoS One. 9:103282. PubMed
  335. Chen Z, et al. 2016. Innate Immunity. 22: 419 - 432. PubMed
  336. Cai W, et al. 2019. J Neuroinflammation. 0.788194444. PubMed
  337. Fernando N, et al. 2020. Front Cell Dev Biol. 0.691666667. PubMed
  338. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
  339. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  340. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  341. Steinmetz TD, et al. 2021. Autophagy. 17:2238. PubMed
  342. Hohsfield LA, et al. 2021. Elife. 10:. PubMed
  343. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  344. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  345. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  346. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
  347. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  348. Wong PP, et al. 2020. Cell. 181(6):1346-1363.e21. PubMed
  349. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  350. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  351. Dougan M, et al. 2018. Cancer Immunol Res. 6:389. PubMed
  352. Abdel Malik R, et al. 2017. Circ Res. 120:99. PubMed
  353. K K, et al. 2016. Haematologica. 151159. PubMed
  354. Han J, et al. 2015. Cancer Res . 75: 5273 - 5282. PubMed
RRID
AB_312790 (BioLegend Cat. No. 101207)
AB_312791 (BioLegend Cat. No. 101208)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS B550™ anti-mouse/human CD11b M1/70 FC
Spark YG™ 581 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
StarBright UltraViolet 575 anti-mouse/human CD11b M1/70 FC
StarBright UltraViolet 740 anti-mouse/human CD11b M1/70 FC
Spark PLUS V475™ anti-mouse/human CD11b M1/70 FC
Go To Top Version: 2    Revision Date: 03.14.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account